2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
Thematic investing has grown immensely in popularity since 2019. At the heart of this movement is Ark Invest, a family of exchange-traded funds (ETFs) shepherded by renowned investor Cathie Wood. The central theme of Wood's Ark Invest is disruption. Ark's goal is to identify and invest in companies with technologies capable of upending the status quo. As a result, Wood's ETFs often buy companies operating in the fields of autonomous vehicles, genomic medicine, and next-generation medical technologies.
Although true disruption is extremely rare, this fact hasn't stopped some Wall Street analysts from handing out noteworthy price targets for some of Wood's holdings. 908 Devices (NASDAQ: MASS) and Beam Therapeutics (NASDAQ: BEAM) are prime examples. The consensus price targets for these two ARK holdings imply upside potentials of 49% and 65%, respectively. Are these two small-cap healthcare stocks a buy? Let's take a look under the hood to find out.
Image Source: Getty Images.
Source Fool.com
